Financial Performance - Total investment income for Q1 2024 was $2.8 million, with total expenses of $2.9 million, resulting in a net investment loss of $(0.1) million or $(0.01) per share[2][5] - Total investment income for Q1 2024 was $2,760,247, up from $2,457,839 in Q1 2023, marking a year-over-year increase of approximately 12.3%[18] - Net investment income (loss) for Q1 2024 was $(79,809), a decrease from $1,370,723 in Q1 2023, showing a decline of approximately 105.8%[18] - The net increase in net assets resulting from operations for Q1 2024 was $519,811, down from $2,357,080 in Q1 2023, representing a decrease of about 77.9%[18] Asset and Liability Management - Total assets increased to $90,351,075 as of March 31, 2024, up from $88,576,271 on December 31, 2023, representing a growth of approximately 2.0%[17] - Total liabilities increased significantly to $5,832,308 as of March 31, 2024, compared to $3,023,653 at the end of 2023, indicating a rise of about 92.9%[17] - Cash and cash equivalents increased to $33,160,294 as of March 31, 2024, compared to $32,611,635 at the end of 2023, indicating a growth of about 1.7%[17] Investment Portfolio - The investment portfolio had a fair value of $54.8 million, consisting of $46.6 million in secured loans and $8.2 million in secured notes[8] - A net unrealized gain of $0.6 million was recorded during the quarter, primarily related to the fair valuation of debt investments[6] - There were no loans on non-accrual status as of March 31, 2024[8] Shareholder Returns - The company declared a cash dividend of $0.25 per share, payable on June 28, 2024, to stockholders of record on June 20, 2024[2][9] - Net asset value (NAV) per share decreased from $13.77 on December 31, 2023, to $13.60 on March 31, 2024, primarily due to dividend payments[7] - The net asset value per share decreased to $13.60 as of March 31, 2024, from $13.77 at the end of 2023, reflecting a decline of approximately 1.2%[17] Future Outlook - The company anticipates increased cannabis capital markets activity in the second half of 2024 due to potential regulatory changes[3] - The company expects to deploy capital to new portfolio companies with favorable risk/reward characteristics in the foreseeable future[3] - The company entered into an agreement to acquire a loan portfolio from Chicago Atlantic Loan Portfolio, LLC, in exchange for newly issued shares[4] Operational Expenses - Management fees for Q1 2024 were $246,131, slightly up from $238,419 in Q1 2023, showing an increase of approximately 3.0%[18] - Non-control/non-affiliate investment income rose to $2,726,497 for the three months ended March 31, 2024, compared to $2,457,839 for the same period in 2023, reflecting an increase of about 10.9%[18] Share Statistics - The weighted average shares outstanding for Q1 2024 were 6,214,941, compared to 6,214,672 in Q1 2023, reflecting a slight increase of about 0.4%[18]

Financial Performance - Total investment income for the three months ended March 31, 2024, was $2,760,247, an increase of 12.3% compared to $2,457,839 for the same period in 2023[7]. - Total expenses for the same period were $2,840,056, significantly higher than $1,087,116 in the prior year, reflecting a rise in transaction expenses related to the Loan Portfolio Acquisition[7]. - Net investment income (loss) for the quarter was $(79,809), a decrease from $1,370,723 in the previous year, indicating a substantial decline in profitability[7]. - The net increase in net assets resulting from operations was $519,811, down from $2,357,080 in the same quarter last year[7]. - The net investment income (loss) per share was $(0.01), compared to $0.22 for the same period in 2023, highlighting a significant drop in earnings per share[7]. - The net increase (decrease) in net assets resulting from operations per share was $0.08, down from $0.38 in the prior year[7]. - The company reported a net cash provided by operating activities of $2,103,079 for the three months ended March 31, 2024, compared to $(2,581,293) for the same period in 2023[9]. - The total net increase in net assets from capital transactions was $74 for the three months ended March 31, 2024[8]. - The company declared a quarterly dividend of $0.25 per share on March 8, 2024, resulting in total dividends paid of $1,553,662[51]. - The net asset value at the end of the period was $13.60 per share, down from $14.29 at the end of March 31, 2023[65]. Investment Portfolio - The fair value of the investment in Curaleaf Holdings, Inc. was reported at $4,208,000, representing 4.98% of net assets[10]. - The total portfolio investments and cash equivalents amounted to $86,763,000, which is 104.13% of net assets[13]. - As of March 31, 2024, total investments in debt securities amounted to $53,603,000, representing 64.90% of the company's net assets[14]. - The company holds cash equivalents of $33,160,000, which accounts for 39.23% of total assets[14]. - The aggregate fair value of non-qualifying assets is $25,291,000, or 28.0% of the company's total assets as of March 31, 2024[14]. - The fair value of investments is determined using a multi-step valuation process, with quarterly assessments conducted by the Adviser[23]. - The company’s investments are categorized entirely at level 3, indicating that 100% of the portfolio requires significant estimates for fair value measurement[102]. - The investment portfolio had an aggregate fair value of approximately $54.8 million, consisting of approximately $46.6 million in first lien, senior secured loans and approximately $8.2 million in senior secured notes[84]. - The geographic composition of the portfolio shows 46.7% in the West and 45.8% in the Midwest as of March 31, 2024[36]. - The entire portfolio is concentrated in the wholesale trade industry, representing 100% of the amortized cost and fair value as of both March 31, 2024, and December 31, 2023[87]. Transaction Expenses - The company incurred transaction expenses of $2,106,050 related to the Loan Portfolio Acquisition, which was not present in the prior year[7]. - Transaction expenses related to the Loan Portfolio Acquisition increased to $2,817,314 as of March 31, 2024, from $711,264 as of December 31, 2023[32]. - The Company incurred capital gains incentive fee expenses of $119,924 for the three months ended March 31, 2024[48]. Risk Management - The company manages various risks including market risk, credit risk, and liquidity risk, particularly in the cannabis sector[39]. - The company is subject to financial market risks, including valuation risk, interest rate risk, and credit risk[111]. - Credit risk is associated with the risk of default or non-performance by portfolio companies, which is equivalent to the investment's carrying amount[87]. Future Plans and Strategy - The company plans to acquire a loan portfolio from Chicago Atlantic Loan Portfolio, LLC, with the transaction expected to close in mid-2024[19]. - A joint venture with Chicago Atlantic BDC Holdings, LLC is set to be established, which will lead to a new investment advisory agreement[19]. - The company has expanded its investment strategy to include companies outside of the cannabis and health and wellness sectors effective April 22, 2024[19]. - The company aims to maximize risk-adjusted returns on equity for shareholders by investing primarily in secured and unsecured debt, equity warrants, and direct equity investments in privately held cannabis businesses[80]. - The company is currently reviewing approximately $425 million of potential investments in various stages of underwriting[25]. Shareholder Information - Weighted average shares outstanding for the quarter were 6,214,941, slightly up from 6,214,672 in the previous year[7]. - SSC holds approximately 72% of the Company's voting stock, allowing substantial control over corporate actions[48]. - The Company plans to hold a stockholder meeting to obtain approvals required for the Loan Portfolio Acquisition[72]. Tax and Compliance - The company intends to maintain its tax treatment as a RIC, requiring it to distribute at least 90% of its investment company taxable income[30]. - The company follows U.S. GAAP for financial reporting, requiring management to make estimates and assumptions that could materially affect reported amounts[99].

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from______ to______ Commission file number: 001-40564 SILVER SPIKE INVESTMENT CORP. (Exact name of registrant as specified in its charter) Maryland 86-2872887 (State or ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-40564 SILVER SPIKE INVESTMENT CORP. (Exact name of registrant as specified in its charter) Maryland 86-2872887 (State or other jurisdiction of incorporation ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-40564 SILVER SPIKE INVESTMENT CORP. (Exact name of registrant as specified in its charter) Maryland 86-2872887 (State or other jurisdiction of incorporation or or ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-40564 (State or other jurisdiction Securities registered pursuant to Section Title of Each Class Trading Symbol(s) Name of each exchange on which registered Comm ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended September 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Address of principal executive offices) (Zip Code) (212) 905-4923 (Registrant's telephone number, including area code) Commission file number: 001-40564 SILVER SPIKE INVESTMENT CORP. ( ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended June 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-40564 SILVER SPIKE INVESTMENT CORP. (Exact name of registrant as specified in its charter) Maryland 86-2872887 (State or other jurisdiction of incorporation or or ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Period Ended March 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-40564 SILVER SPIKE INVESTMENT CORP. (Exact name of registrant as specified in its charter) Maryland 86-2872887 (State or other jurisdiction of incorporation or organiz ...